Transforming Cardiovascular Care: The Rise of Drug-Eluting Devices
Introduction The drug-eluting device market was estimated at USD 3.2 billion in 2023 and is likely to grow at a CAGR of 5.9% during 2024-2030 to reach USD 4.9 billion in 2030. These medical devices, including drug-eluting stents (DES), drug-eluting balloons (DEB), and implantable devices, are revolutionizing the treatment of cardiovascular diseases by delivering...
0 Comments 0 Shares 65 Views 0 Reviews